Charles III Calderaro
CIK 2049888 · Chief Technical Officer · last filed 2026-02-27
Charles III Calderaro is a Chief Technical Officer who has filed 4 SEC Form 4 insider transactions across 2 companies since 2025. The most recent filing, for RNAM, was dated Feb 27, 2026. Across all open-market trades the lifetime net is −$269.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $572.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$572.2K
2
4
-$269.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) Delisted | Chief Technical Officer | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Chief Technical Officer | 49,797 | $11.49 | $572.2K | -$269.2K | 3 | 2026-01-09 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) Delisted | Disp (D) | −98,547 | $0 | EDGAR |
| 2026-01-09 | RNA | Sell (S) | −3,727 | -$269.2K | EDGAR |
| 2025-12-19 | RNA | Mixed | +13,524 | -$699.0K | EDGAR |
| 2025-01-08 | RNA | Grant (A) | +40,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.